Cargando…

FGFR3–TACC3: A novel gene fusion in cervical cancer

Cervical cancer epitomizes the success of cancer prevention through the human papillomavirus (HPV) vaccine, but significant challenges remain in the treatment of advanced disease. We report the first three cases of cervical carcinoma harboring an FGFR3–TACC3 fusion, which serves as a novel therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carneiro, Benedito A., Elvin, Julia A., Kamath, Suneel D., Ali, Siraj M., Paintal, Ajit S., Restrepo, Alvaro, Berry, Emily, Giles, Francis J., Johnson, Melissa L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563584/ https://www.ncbi.nlm.nih.gov/pubmed/26425723 http://dx.doi.org/10.1016/j.gore.2015.06.005

Ejemplares similares

FGFR3-TACC3 fusion in solid tumors: mini review
por: Costa, Ricardo, et al.
Publicado: (2016)

Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions
por: Tamura, Ryo, et al.
Publicado: (2018)

FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium
por: Best, Sarah A., et al.
Publicado: (2018)

FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma
por: Gött, Hanna, et al.
Publicado: (2022)

A metabolic function of FGFR3-TACC3 gene fusions in cancer
por: Frattini, Véronique, et al.
Publicado: (2018)

FGFR3–TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindle
por: Sarkar, Sourav, et al.
Publicado: (2017)

Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
por: Mata, Douglas A., et al.
Publicado: (2020)

Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion
por: Métais, Alice, et al.
Publicado: (2023)

Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases
por: Ballester, Leomar Y., et al.
Publicado: (2019)

RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine
por: Parker Kerrigan, Brittany C, et al.
Publicado: (2020)

Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples
por: Kurobe, Masahiro, et al.
Publicado: (2016)

Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients
por: Ou, Sai-Hong Ignatius, et al.
Publicado: (2017)

Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling
por: Nelson, Katelyn N., et al.
Publicado: (2018)

Successful Treatment and Retreatment With Erdafitinib for a Patient With FGFR3-TACC3 Fusion Squamous NSCLC: A Case Report
por: Pham, Chi, et al.
Publicado: (2023)

FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling
por: Daly, C, et al.
Publicado: (2017)

Aberrations of TACC1 and TACC3 are associated with ovarian cancer
por: Lauffart, Brenda, et al.
Publicado: (2005)

Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis
por: Lombardi, Benedetta, et al.
Publicado: (2017)

Histology-specific FGFR2 alterations and FGFR2-TACC2 fusion in mixed adenoid cystic and neuroendocrine small cell carcinoma of the uterine cervix
por: Gill, Corey M., et al.
Publicado: (2020)

TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
por: Ha, Geun-Hyoung, et al.
Publicado: (2013)

TACC3 in personalized medicine
por: Murata, Stephen, et al.
Publicado: (2015)

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability
por: Wang, Clark G., et al.
Publicado: (2023)

Correction: TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer
por: Ha, Geun-Hyoung, et al.
Publicado: (2013)

Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review
por: Broggi, Giuseppe, et al.
Publicado: (2022)

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
por: Granberg, Kirsi J, et al.
Publicado: (2017)

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
por: Weickhardt, Andrew J., et al.
Publicado: (2022)

Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine
por: Tong, Zhou, et al.
Publicado: (2020)

Stage 4 pancreatic adenocarcinoma harbouring an FGFR2-TACC2 fusion mutation with complete response to erdafitinib a pan-fibroblastic growth factor receptor inhibitor
por: Poon, Donald, et al.
Publicado: (2021)

TACC3 Is Important for Correct Progression of Meiosis in Bovine Oocytes
por: Mahdipour, Mahdi, et al.
Publicado: (2015)

Oncogenic FGFR3 gene fusions in bladder cancer
por: Williams, Sarah V., et al.
Publicado: (2013)

TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis
por: Du, Yong, et al.
Publicado: (2016)

TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma
por: Zhou, Dong-Sheng, et al.
Publicado: (2015)

SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib
por: Ohoka, Nobumichi, et al.
Publicado: (2017)

Rate and risk factors for pediatric cervical spine fusion pseudarthrosis: opportunity for improvement
por: Compton, Edward, et al.
Publicado: (2023)

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
por: Chae, Young Kwang, et al.
Publicado: (2016)

Clinical and biological characteristics of cervical neoplasias with FGFR3 mutation
por: Rosty, Christophe, et al.
Publicado: (2005)

Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes
por: Duncan, Christopher G., et al.
Publicado: (2010)

DOCK7 interacts with TACC3 to regulate interkinetic nuclear migration and cortical neurogenesis
por: Yang, Yu-Ting, et al.
Publicado: (2012)

Impact of NPM, TFF3 and TACC1 on the Prognosis of Patients with Primary Gastric Cancer
por: Ding, Aiping, et al.
Publicado: (2013)

High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis
por: Huang, Zhi-Liang, et al.
Publicado: (2015)

Aurora-A-Dependent Control of TACC3 Influences the Rate of Mitotic Spindle Assembly
por: Burgess, Selena G., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gm9s788ij5pddqkj07urijvlag